ir - perpustakaan universitas airlangga 78repository.unair.ac.id/89583/3/tkkli. 72-19 ang p...
TRANSCRIPT
-
78
DAFTAR PUSTAKA
Abd El-Aziz, S.E. 2012. Antinuclear antibodies and glutamic acid decarboxylase
antibodies in children with refractory epilepsy. Egyptian. Pediatric.
Association. Gazette. 46–51.
Ali, C., S. Ayse., Y. Deniz., D, Vehbi., O. Secil and H. Tugbna. Prevalence of
some risk factors in childhood with epilepsy compared to their controls.
Seizure. 2007.16: 338-344.
Andrianti, P. T. dan P. F. Gunawan. 2016. Profil Epilepsi Anak dan Keberhasilan
Pengobatannya di RSUD Dr. Soetomo Tahun 2013. Sari. Pediatri. 18: 34-39.
Aneja, S. and P. Jain. 2014. Refractory Epilepsy in Children. The. Ind. Jour. of.
Ped. 81: 1063-1072.
Baekkeskov, S., H.J. Aanstoot and S. Christgau. 1990. Identification of the 64K
autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme
glutamic acid decarboxylase. Nature. 347: 151-156.
Beleza, P. 2009. Refractory epilepsy: a clinically oriented review. Eur. Neuro. 62:
65-71.
Bien, C.G. and I. E. Scheffer. 2011. Autoantibodies and epilepsy. Epilepsia. 52
Suppl 3: 18-22.
Brenner, T., G.J. Sills dan Y. Hart. 2013. Prevalence of neurologic autoantibodies
in cohorts of patients with new and established epilepsy. Epilepsia. 54. 1028-
1035.
Ceyhan, D. A., S. Elibirlik., A. Koksal., M. Özturk., Y. Altunkaynak., S. Baybas.,
and A. Dirican. 2016. Evaluation of Glutamic Acid Decarboxylase Antibody
Levels in Patients with Juvenile Myoclonic Epilepsy and Mesial Temporal
Lobe Epilepsy with Hippocampal Sclerosis. Noro. Psikiyatr. Ars. 53. 253-256
Cho, C.H. 2013. New mechanism for glutamate hypothesis in epilepsy. Front Cell
Neurosci. 7:233-250
Choi, D.W. 1993. Nitric oxide: foe or friend to the injured brain? Proc. Natl.
Acad. Sci USA. 90. 9741-9743.
Christensen, J., M. J. Kjeldsen., H. Andersen., M. L. Friis and P. Sidenius. 2005.
Gender differences in epilepsy. Epilepsia. 46. 956-960.
IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
TESIS PERBANDINGAN KADAR AUTOANTIBODI….. Novi Dwi Anggraini
-
79
Christgau, S., H. Schierbeck and H.J. Aanstoot. 1991. Pancreatic beta cells
express two autoantigenic forms of glutamic acid decarboxylase, a 65-kDa
hydrophilic form and a 64-kDa amphiphilic form which can be both
membrane-bound and soluble. J. Biol. Chem. 266: 21257-21264.
Çoban, A., E. Ekizoğlu and E. Tüzün. 2013. Epilepsy and Autoimmunity. Journal.
of. the. Turkish. Chapter of ILAE. 19: 39-47.
Coulter, D. A. and T. Eid. 2012. Astrocytic regulation of glutamate homeostasis
in epilepsy. Glia. 60. 1215-26.
Crotti, C and C. Selmi. 2014. Glutamic Acid Decarboxylase Antibody, Italy. 630-
658.
Dash, P.,K., S. A. Mach and A. N. Moore. 2001. Enhanced neurogenesis in the
rodent hippocampus following traumatic brain injury. J. Neurosci. Res. 63.
313-319.
De Deyn PP and R. L. Macdonald. 1990. Guanidino compounds that are increased
in cerebrospinal fluid and brain of uremic patients inhibit GABA and glycine
responses on mouse neurons in cell culture. Ann. Neurol. 28. 627-633.
Del-bel EA, P.R. Oliveira., J. A. Oliviera., P. K. Mishra., P. C. Jobe., and N.
Garcia-Cairasco. 1997. Anticonvulsant and proconvulsant roles of nitric
oxide in experimental epilepsy models. Braz. J. Med. Biol. Res. 30. 971-979.
Dinkel K., H. M. Meinck., K. M. Jury., W. Karges and W. Richter. 1998.
Inhibition of gamma-aminobutyric acid synthesis by glutamic acid
decarboxylase autoantibodies in stiff-man syndrome. Ann. Neurol. 44: 194-
201.
Dubey, D., A. Alqallaf., R. Hays., M. Freeman., K. Chen., K. Ding., M. Agostini.,
S. Vernino. 2017. Neurological Autoantibody Prevalence in Epilepsy of
Unknown Etiology. JAMA Neurol. 74: 397-402.
Dubey, D., K. Blackburn., B. Greenberg., O. Stuve and S. Vernino. 2016.
Diagnostic and therapeutic strategies for management of autoimmune
encephalopathies. Expert. Rev. Neurother. 16: 937-949.
Eeg-Olofsson, O. 2003. Virological and immunological aspects of seizure
disorders. Brain. Dev. 25. 9-13.
IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
TESIS PERBANDINGAN KADAR AUTOANTIBODI….. Novi Dwi Anggraini
-
80
Eid, T., M. J. Thomas., D. D. Spencer., E. Ruden-Pran., J. C. Lai., G. V.
Malthankar., J. H. Kim., N. C. Danbolt., O. P. Ottersen and N. C. de
Lanerolle. 2004. Loss of glutamine synthetase in the human epileptogenic
hippocampus: possible mechanism for raised extracellular glutamate in
mesial temporal lobe epilepsy. Lancet, 363, 28-37. .
Engelborghs, S., R. D'hooge and P. P. De Deyn. 2000. Pathophysiology of
epilepsy. Acta Neurol Belg. 100: 201-13.
Errichiello, L., G. Perruolo., A. Pascarella., P. Formisano., C. Minetti., S. Striano.,
F. Zara and P. Striano 2009. Autoantibodies to glutamic acid decarboxylase
(GAD) in focal and generalized epilepsy: A study on 233 patients. J.
Neuroimmunol. 211. 120-123.
Errichiello, L., S. Striano., F. Zara and P. Striano. 2011. Temporal lobe epilepsy
and anti glutamic acid decarboxylase autoimmunity. Neurol. Sci. 32. 547-
550.
Falip, M., M. Carreno., J. Miro., A. Saiz., V. Villanueva., A. Quilez., A. Molins.,
I. Barcelo., A. Sierra and F. Graus. 2012. Prevalence and immunological
spectrum of temporal lobe epilepsy with glutamic acid decarboxylase
antibodies. Eur. J. Neurol. 19. 827-833.
Faulkner-Jones, B. E., D. S. Cram., J. Kun and L. C. Harrison. 1993. Localization
and quantitation of expression of two glutamate decarboxylase genes in
pancreatic beta-cells and other peripheral tissues of mouse and rat.
Endocrinology. 133: 2962-2972.
Fenalti, G., R. H. Law., A. M. Buckle., C. Langendorf., K. Tuck., C. J. Rosado.,
N. G. Faux., K. Mahmood., C. S. Hampe., J. P. Banga., M. Wilce., J.
Schmidberger., J. Rossjohn., O. El-Kabbani., R. N. Pike., A. I. Smith., I. R.
Mackay., M. J. Rowley and J. C. Whisstock. 2007. GABA production by
glutamic acid decarboxylase is regulated by a dynamic catalytic loop. Nat.
Struct. Mol. Biol. 14: 280-286.
Fisher, R. S., C. Acevedo and A. Arzimanoglou. 2014. ILAE official report: a
practical clinical definition of epilepsy. Epilepsia. 55: 475-482.
Fujikawa, D.G. 2015. The role of excitotoxic programmed necrosis in acute brain
injury. Comput. Struct. Biotechnol. J. 13: 212-221.
IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
TESIS PERBANDINGAN KADAR AUTOANTIBODI….. Novi Dwi Anggraini
-
81
Gaillard, W.D., C. Chiron., J. H. Cross., A. S. Harvey., R. Kuzniecky., L. Hertz-
pannier and L. G. Vezina. 2009. Guidelines for imaging infants and children
with recent-onset epilepsy. Epilepsia. 50: 2147-53.
Gasparini, S., E. Ferlazzo., E. Beghi., V. Sofia., L. Mumoli., A. Labate., V.
Cianci., D. Fatuzzo., M. A. Bellavia., L. Arcudi., E. Russo., G. De Sarro., A.
Gambardella and U. Aguglia. 2015. Epilepsy associated with Leukoaraiosis
mainly affects temporal lobe: a casual or causal relationship? Epilepsy. Res.
109: 1-8.
Gayatri, N. A., C. D. Ferrie and H. Cross. 2007. Corticosteroids including ACTH
for childhood epilepsy other than epileptic spasms. Cochrane. Database. Syst.
Rev. Cd005222.
Geng, J., J. Dong., Y. Li., H. Ni., K. Jiang., L. L. Shi and G. Wang. 2011.
Intravenous immunoglobulins for epilepsy. Cochrane. Database. Syst. Rev.
Cd008557.
Gibson, L.M., M. F. Hanby., S. M. Al-Bachari., L. M. Parkes., S. M. Allan and H.
C. Emsley. 2014. Late-onset epilepsy and occult cerebrovascular disease. J.
Cereb. Blood. Flow. Metab. 34: 564-570.
Giometto, B., P. Nicolao., M. Macucci., B. Tavolato., R. Foxon, and G. F.
Bottazzo. 1998. Temporal-lobe epilepsy associated with glutamic-acid-
decarboxylase autoantibodies. Lancet. 352: 457.
Glauser, T., E. Ben-Menachem., B. Bourgeois., A. Cnaan., D. Chadwick., C.
Guerreiro., R. Kalviainen., R. Mattson., E. Perucca and T. Tomson. 2006.
ILAE treatment guidelines: evidence-based analysis of antiepileptic drug
efficacy and effectiveness as initial monotherapy for epileptic seizures and
syndromes. Epilepsia. 47: 1094-1120.
Glauser, T., G. Kluger., R. Sachdeo., G. Krauss., C. Perdomo and S. Arroyo.
2008. Rufinamide for generalized seizures associated with Lennox-Gastaut
syndrome. Neurology. 70: 1950-1958.
Gonzalez-Martinez, J. A., A. Gupta and P. Kotagal. 2005. Hemispherectomy for
catastrophic epilepsy in infants. Epilepsi. 46: 1518-25.
Graber, K. D., and A. Prince. 1999. Tetrodotoxin prevents posttraumatic
epileptogenesis in rats. Ann. Neurol. 46. 234-242.
IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
TESIS PERBANDINGAN KADAR AUTOANTIBODI….. Novi Dwi Anggraini
-
82
Had-Aissouni, L. 2012. Toward a new role for plasma membrane sodium-
dependent glutamate transporters of astrocytes: maintenance of antioxidant
defenses beyond extracellular glutamate clearance. Amino. Acids. 42. 181-
197.
Hardingham, G. E., and H. Bading. 2002. Coupling of extrasynaptic NMDA
receptors to a CREB shut-off pathway is developmentally regulated.
Biochim. Biophys. Acta. 1600: 148-153.
Holmseth, S., Y. Zhou., V. V. Follin-Arbelet., K. P. Lehre., D. E. Bergles and N.
C. Danbolt. 2012. Specificity controls for immunocytochemistry: the antigen
preadsorption test can lead to inaccurate assessment of antibody specificity. J.
Histochem. Cytochem. 60: 174-187.
Hussain, S. and R. Sankar. 2011. Pharmacologic treatment of intractable epilepsy
in children: a syndrome-based approach. Semin. Pediatr. Neurol. 18: 171-
178.
Institute Of Medicine Forum On Microbial. 2004. The National Academies
Collection: Reports funded by National Institutes of Health. In: Knobler, S.
L., S. O'connor., S. M. Lemon and M. Najafi (eds.) The Infectious Etiology of
Chronic Diseases: Defining the Relationship, Enhancing the Research, and
Mitigating the Effects: Workshop Summary. Washington (DC): National
Academies Press (US)
Irani, S. R., S. Alexander., P. Waters., K. A. Kleopa., P. Pettingill., L. Zuliani., E.
Peles., C. Buckley., B. Lang and A. Vincent. 2010. Antibodies to Kv1
potassium channel-complex proteins leucine-rich, glioma inactivated 1
protein and contactin-associated protein-2 in limbic encephalitis, Morvan's
syndrome and acquired neuromyotonia. Brain. 133: 2734-2748.
Ishida, K., H. Mitoma., Y. Wada., T. Oka., J. Shibahara., Y. Saito., S. Murayama
and H. Mizusawa. 2007. Selective loss of Purkinje cells in a patient with
anti‐glutamic acid decarboxylase antibody‐associated cerebellar ataxia. J.
Neurol. Neurosurg. Psychiatry. 78: 190-192.
Kanter, I. C., H. B. Huttner., D. Staykov., T. Biermann., T. Struffert., F. Kerling.,
M. J. Hilz., P. D. Schellinger., S. Schwab and J. Bardutzky. 2008.
Cyclophosphamide for anti-GAD antibody-positive refractory status
epilepticus. Epilepsia. 49: 914-920.
IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
TESIS PERBANDINGAN KADAR AUTOANTIBODI….. Novi Dwi Anggraini
-
83
Kash, S. F., R. S. Johnson., L. H. Tecott., J. L. Noebels., R. D. Mayfield., D.
Hanahan and S. Baekkeskov. 1997. Epilepsy in mice deficient in the 65-kDa
isoform of glutamic acid decarboxylase. Proc. Natl. Acad. Sci. USA. 94:
14060-14065.
Ko, T. S., and G. L. Holmes. 1999. EEG and clinical predictors of medically
intractable childhood epilepsy. Clin. Neurophysiol. 110: 1245-1251.
Kossoff, E. H. 2011. Intractable childhood epilepsy: choosing between the
treatments. Semin. Pediatr. Neurol. 18: 145-149.
Kotagal, P. 2011. Neurostimulation: vagus nerve stimulation and beyond. Semin.
Pediatr. Neurol. 18: 186-194.
Kwan, P., A. Arzimanoglou., A. T. Berg., M. J. Brodie., W. Allen hauser., G.
Mathern., S. L. Moshe., E. Perucca., S. Wiebe and J. French. 2010. Definition
of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the
ILAE Commission on Therapeutic Strategies. Epilepsia. 51: 1069-1077.
Kwan, P., G. J. Sills., K. Kelly., E. Butler and M. J. Brodie. 2000. Glutamic acid
decarboxylase autoantibodies in controlled and uncontrolled epilepsy: a pilot
study. Epilepsy. Res. 42: 191-195.
Lancaster, E., E. Martinez-Hernandez and J. Dalmau. 2011. Encephalitis and
antibodies to synaptic and neuronal cell surface proteins. Neurology. 77: 179-
189.
Levite, M and Y. Ganor. 2008. Autoantibodies to glutamate receptors can damage
the brain in epilepsy, systemic lupus erythematosus and encephalitis. Expert.
Rev. Neurother. 8: 1141-1160.
Levy, R. G., P. N. Cooper and P. Giri. 2012. Ketogenic diet and other dietary
treatments for epilepsy. Cochrane. Database. Syst. Rev. Cd001903.
Liimatainen, S. P. M., L. Sabater., M. Fallah., E. Kharazmi., A. M. Haapala., P.
Dastidar., M. Knip., A. Saiz and J. Peltola. 2010. Clinical significance of
glutamic acid decarboxylase antibodies in patients with epilepsy. Epilepsia.
51(5): 760–767.
Lilleker, J. B., V. Biswas and R. Mohanraj. 2014. Glutamic acid decarboxylase
(GAD) antibodies in epilepsy: diagnostic yield and therapeutic implications.
Seizure. 23: 598-602.
Luft, S. R., A. Kaelin-Lang and T. K. Hauser. 2002. Modulation of rodent cortical
motor excitability by somatosensory input. Exp. Brain. Res. 142: 562-569.
IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
TESIS PERBANDINGAN KADAR AUTOANTIBODI….. Novi Dwi Anggraini
-
84
Mäkelä, K. M., A. Hietaharju., A. Brander and J. Peltola. 2018. Clinical
Management of Epilepsy With Glutamic Acid Decarboxylase Antibody
Positivity: The Interplay Between Immunotherapy and Anti-epileptic Drugs.
Front. Neurol. 9: 579.
Mandolesi, G., A. Musella., A. Gentile., G. Grasselli., N. Haji., H. Sepman., D.
Fresegna., S. Bullitta., F. De vito., G. Musumeci., C. Di sanza., P, strata and
D. Centonze. 2013. Interleukin-1beta alters glutamate transmission at
purkinje cell synapses in a mouse model of multiple sclerosis. J. Neurosci.
33: 12105-12121.
Manto, M. U., M. A. Laute., M. Aguera., V. Rogemond., M. Pandolfo and J.
Honnorat. 2007. Effects of anti-glutamic acid decarboxylase antibodies
associated with neurological diseases. Ann. Neurol. 61. 544-551.
Mata, S., G. C. Muscas., I. Naldi., E. Rosati., S. Paladini., B. Cruciatti., F. Bisulli.,
M. Paganini., G. Mazzi., S. Sorbi and P. Tinuper. 2008. Non-paraneoplastic
limbic encephalitis associated with anti-glutamic acid decarboxylase
antibodies. J. Neuroimmunol. 199: 155-159.
Mathews, G. C. 2007. The dual roles of GABA in seizures and epilepsy generate
more excitement. Epilepsy. Curr. 7: 28-30.
Mc Hugh, J. C. and N. Delanty. 2008. Epidemiology and classification of
epilepsy: gender comparisons. Int. Rev. Neurobiol. 83: 11-26.
Mckenna, M. C. 2007. The glutamate-glutamine cycle is not stoichiometric: fates
of glutamate in brain. J. Neurosci. Res. 85: 3347-3358.
Mcknight, K., Y. Jiang., Y. Hart., A. Cavey., S. Wroe., M. Blank., Y. Shoenfeld.,
A. Vincent., J. Palace and B. Lang. 2005. Serum antibodies in epilepsy and
seizure-associated disorders. Neurology. 65: 1730-1736.
Menon, B and S. D. Shorvon. 2009. Ischaemic stroke in adults and epilepsy.
Epilepsy. Res. 87: 1-11.
Mitoma, H. M. M. and C. S. Hampe. 2017. Immune-mediated cerebellar ataxias:
from bench to bedside. Cerebellum & Ataxias. vol. 4: 1.
Molyneux, M. E. 2000. Impact of malaria on the brain and its prevention. Lancet.
355. 671-672.
Morais, N. M., J. Ranzan and R. S. Riesgo. 2013. Predictors of Epilepsy in
Children With Cerebrovascular Disease. J. Child. Neurol. 28: 1387-1391.
IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
TESIS PERBANDINGAN KADAR AUTOANTIBODI….. Novi Dwi Anggraini
-
85
Morris, G. L., D. Gloss., J. Buchhalter., K. J. Mack., K. Nickels and C. Harden.
2013. Evidence-based guideline update: vagus nerve stimulation for the
treatment of epilepsy: report of the Guideline Development Subcommittee of
the American Academy of Neurology. Neurology. 81: 1453-1459.
Niehusmann, P., J. Dalmau., C. Rudlowski., A. Vincent., C. E. Elger., J. E. Rossi
and C. G. Bien. 2009. Diagnostic value of N-methyl-D-aspartate receptor
antibodies in women with new-onset epilepsy. Arch. Neurol. 66: 458-464.
Nitkunan, A., S. Lanfranconi., R. A. Charlton, T. R. Barrick and H. S. Markus.
2011. Brain atrophy and cerebral small vessel disease: a prospective follow-
up study. Stroke. 42. 133-138.
Nortje,J and D. K. Menon. 2004. Traumatic brain injury: physiology,
mechanisms, and outcome. Curr. Opin. Neurol. 17: 711-718.
Olmos, G. 2014. Tumor Necrosis Factor Alpha: A Link between
Neuroinflammation and Excitotoxicity. Mediators. of. Inflammation. 2014:
12.
Oulad Ben Taib, N., M. A. Laute., M. Pandolfo and M. U. Manto. 2004.
Interaction between repetitive stimulation of the sciatic nerve and functional
ablation of cerebellar nucleus interpositus in the rat. Cerebellum. 3. 21-26.
Pal, D. K., A. W. Pong and W. K Chung. 2010. Genetic evaluation and counseling
for epilepsy. Nat. Rev. Neurol. 6: 445-453.
Pantoni, L. 2010. Cerebral small vessel disease: from pathogenesis and clinical
characteristics to therapeutic challenges. Lancet. Neurol. 9. 689-701.
Peltola, J., P. Kulmala., J. Isojarvi., A. Saiz., K. Latvala., J. Palmio., K. Savola.,
M. Knip., T. Keranen and F. Graus. 2000. Autoantibodies to glutamic acid
decarboxylase in patients with therapy-resistant epilepsy. Neurology. 55: 46-
50.
Perez, E. L., F. Lauritzen., Y. Wang., T. S. Lee., D. Kang., H. P. Zaveri., F. A.
Chaudhry., O. P. Ottersen., L. H. Bergersen and T. Eid. 2012. Evidence for
astrocytes as a potential source of the glutamate excess in temporal lobe
epilepsy. Neurobiol. Dis. 47. 331-337.
Petroff, O. A. 2002. GABA and glutamate in the human brain. Neuroscientist. 8.
562-573.
IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
TESIS PERBANDINGAN KADAR AUTOANTIBODI….. Novi Dwi Anggraini
-
86
Piccolo, G., E. Tavazzi., T. Cavallaro., A. Romani., R. Scelsi and G Martino.
2010. Clinico-pathological findings in a patient with progressive cerebellar
ataxia, autoimmune polyendocrine syndrome, hepatocellular carcinoma and
anti-GAD autoantibodies. J. Neurol. Sci. 290: 148-149.
Poonam, N. B., H. W. Allen. 2007. Epilepsy. In: Engel, J., T. A. Pedley (ed.)
Epilepsy: a comprehensive textbook. Edisi kedua ed. Philadelphia Lippincott
Williams & Wilkins.
Quek, A. M. L., J. W. Britton., A. Mckeon., E. So., V. A. Lennon., C. Shin., C. J.
Klein., R. E. Watson., A. L. Kotsenas., T. D. Lagerlund., G. D. Cascino., G.
A. Worrell., E. C. Wirrell., K. C. Nickels., A. J. Aksamit., K. H. Noe and S. J.
Pittock. 2012. Autoimmune Epilepsy: Clinical Characteristics and Response
to Immunotherapy. Arch. Neurol. 69: 582-593.
Ramanathan, S., A. Bleasel., J. Parratt., C. Orr., R. C. Dale., A. Vincent and V. S.
Fung. 2014. Characterisation of a syndrome of autoimmune adult onset focal
epilepsy and encephalitis. J. Clin. Neurosci. 21: 1169-1175.
Ramzi., Y. Soenarto., Sunartini., M. Hakimi. 2008. Prognostic factors of
refractory epilepsy in children. Paediatr. Indones. Volume 48: 269-273.
Riviello, J. J., JR., S. Ashwal., D. Hirtz., T. GlauseR., K. Ballaban-gil., K. Kelley.,
L. D. Morton., S. Phillips., E. Sloan and S. Shinnar. 2006. Practice parameter:
diagnostic assessment of the child with status epilepticus (an evidence-based
review): report of the Quality Standards Subcommittee of the American
Academy of Neurology and the Practice Committee of the Child Neurology
Society. Neurology. 67: 1542-1550.
Rosenow, F. and H. Luders. 2001. Presurgical evaluation of epilepsy. Brain. 124:
1683-1700.
Sahoo, P., K. I. Mathai., G. V. Ramdas and M. N. Swamy. 2007. The
pathophysiology of post-traumatic epilepsy. Ind. J. Neurotrauma. 4. 11–14.
Santhakumar, V., A. D. Ratzliff., J. Jeng., Z. Toth and I. Soltesz. 2001. Long-term
hyperexcitability in the hippocampus after experimental head trauma. Ann.
Neurol. 50. 708-717.
Scheffer, I. E., S. Berkovic., G. Capovilla., M. B. Connolly., J. French., L.
Guilhoto., E. Hirsch., S. Jain., G. W. Mathern., S. L. Moshé., D. R. Nordli.,
E. Perucca., T. Tomson., S. Wiebe., Y. H. Zhang and S. M. Zuberi. 2017.
IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
TESIS PERBANDINGAN KADAR AUTOANTIBODI….. Novi Dwi Anggraini
-
87
ILAE classification of the epilepsies: Position paper of the ILAE Commission
for Classification and Terminology. Epilepsia. 58: 512-521.
Schmidli, R. S., P. G. Colman., E. Bonifacio., G. F. Bottazzo and L. C. Harrison .
1994. High level of concordance between assays for glutamic acid
decarboxylase antibodies. The First International Glutamic Acid
Decarboxylase Antibody Workshop. Diabetes. 43: 1005-1009.
Schwartzkroin, P. A., S. C. Baraban and D. W. Hochman. 1998. Osmolarity, ionic
flux, and changes in brain excitability. Epilepsy. Res. 32: 275-285.
Seissler, J., J. Amann., L. Mauch., H. Haubruck., S. Wolfahrt., S. Bieg., W.
Richter., R. Holl., E. Heinze and W. Northemann. 1993. Prevalence of
autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in
insulin-dependent diabetes mellitus. J. Clin. Invest. 92: 1394-1399.
Shinnar, S and J. M. Pellock. 2002. Update on the epidemiology and prognosis of
pediatric epilepsy. J. Child. Neurol. 17. Suppl 1: S4-17.
Silverstein, F. S., B. Naik and J. Simpson. 1991. Hypoxia-ischemia stimulates
hippocampal glutamate efflux in perinatal rat brain: an in vivo microdialysis
study. Pediatr. Res. 30. 587-590.
Spencer, S and L. Huh. 2008. Outcomes of epilepsy surgery in adults and
children. Lancet. Neuro. 7: 525-537.
Stafstrom, C. E. 1998. Back to Basics: The Pathophysiology of Epileptic Seizures:
A Primer For Pediatricians. Ped. in. Rev. 19: 342-351.
Stagg, C. J., B. Lang and J. G. Best., K. McKnight., A. Cavey., H. Johansen-berg.,
A. Vincent and J. Palace. 2010. Autoantibodies to glutamic acid
decarboxylase in patients with epilepsy are associated with low cortical
GABA levels. Epilepsia. 51: 1898-1901.
Suwarba, I. 2011. Insidens dan Karakteristik Klinis Epilepsi pada Anak. Sari.
Pediatri. vol. 13. 123-128.
Suzumura, A. 2013. Neuron-microglia interaction in neuroinflammation. Curr.
Protein. Pept. Sci. 14: 16-20.
Temkin, N. R., S. D. Jarell and G. D. Anderson. 2001. Antiepileptogenic agents:
how close are we?. Drugs. 61. 1045-1055.
IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
TESIS PERBANDINGAN KADAR AUTOANTIBODI….. Novi Dwi Anggraini
-
88
Thiha, A and F. Ibrahim. 2015. A Colorimetric Enzyme-Linked Immunosorbent
Assay (ELISA) Detection Platform for a Point-of-Care Dengue Detection
System on a Lab-on-Compact-Disc. Sensors (Basel). 15: 11431-11441.
Tian, G. F., H. Azmi., T. Takano., Q. Xu., W. Peng., J. Lin., N. A. Oberheim., N.
Lou., R. Zielke., J. Kang and M. Nedergaard. 2005. An astrocytic basis of
epilepsy. Nat. Med. 11. 973-981.
Tjandrajani, A. 2012. Karakteristik kasus epilepsi di Rumah Sakit Anak dan
Bunda Harapan Kita pada tahun 2008-2010. Sari. Pediatri. 14. 143-146.
Topbas, M., S. Ozgun., M. F. Sonmez., A. Aksoy, G. Can., A. Yavuzyilmaz and
E. Can. 2012. Epilepsy prevalence in the 0-17 age group in trabzon, Turkey.
Iran. J. Pediatr. 22. 344-350.
Triono, A dan E. Herini. 2014. Faktor prognostik kegagalan terapi epilepsi pada
anak dengan monoterapi. Sari. Pediatri. 16: 248-253.
Vannucci, R. C., J. R. Connor., D. T. Mauger., C. Palmer., M. B. Smith., J.
Towfighi and S. J. Vannucci. 1999. Rat model of perinatal hypoxic-ischemic
brain damage. J. Neurosci. Res. 55: 158-163.
Verellen, R. M. and J. E. Cavazos. 2010. Post-traumatic epilepsy: an overview.
Therapy. 7: 527-531.
Veri, K., O. Uibo., T. Talvik., I. Talvik., K. Metskula., A. Napa., U. Vaher., E.
Oiglane-slik., R. Rein., A. Kolk., A. Traat and R. Uibo. 2013. Newly-
diagnosed pediatric epilepsy is associated with elevated autoantibodies to
glutamic acid decarboxylase but not cardiolipin. Epilepsy. Res. 105: 86-91.
Vincent A, S. R. Irani and B. Lang. 2010. The growing recognition of
immunotherapy-responsive seizure disorders with autoantibodies to specific
neuronal proteins. Curr. Opin. Neuro. 23: 144-150.
Vincent A, I. S. and B. Lang. 2011. Potentially Pathogenic Autoantibodies
Associated with Epilepsy and Encephalitis in Children and Adults. Epilepsia.
52.(Suppl. 8): 8–11.
Walker, M.C., H. S White and J. W. Sander. 2002. Disease modification in partial
epilepsy. Brain. 125: 1937-1950.
Wall, M. J. 2003. Endogenous nitric oxide modulates GABAergic transmission to
granule cells in adult rat cerebellum. Eur. J. Neurosci. 18. 869-878.
IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
TESIS PERBANDINGAN KADAR AUTOANTIBODI….. Novi Dwi Anggraini
-
89
Welsh, F. A,, R. C. Vannucci and J. B. Brierley. 1982. Columnar alterations of
NADH fluorescence during hypoxia-ischemia in immature rat brain. J. Cereb.
Blood. Flow. Metab. 2: 221-228.
World Health Organization. 1976. The enzyme-linked immunosorbent assay
(ELISA). Bull World Health Organ. 54: 129-139.
Wiest, R., F. Von bredow., K. Schindler., B. Schauble., J. Slotboom., C.
Brekenfeld., L. Remonda., G.schroth and C. Ozdoba. 2006. Detection of
regional blood perfusion changes in epileptic seizures with dynamic brain
perfusion CT--a pilot study. Epilepsy. Res. 72: 102-110.
Wong, W. T., M. Wang dan W. Li. 2011. Regulation of Microglia by Ionotropic
Glutamatergic and GABAergic Neurotransmission. Neuron. Glia. Biol. 7: 41-
46.
Woo, D. H., K. S. Han., J. W. Shim., B. E. Yoon., E. Kim., J. Y. Bae., S.J. Oh.,
E.M. Hwang., A. D. Marmorstein., Y. C. Bae., J. Y. Park and C. J. Lee.
2012. TREK-1 and Best1 channels mediate fast and slow glutamate release in
astrocytes upon GPCR activation. Cell. 151: 25-40.
Yuste, J. E., E. Tarragon., C. M. Campuzano and F. Ros-Bernal. 2015.
Implications of glial nitric oxide in neurodegenerative diseases. Front. Cell.
Neurosci. 9:11-15.
IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
TESIS PERBANDINGAN KADAR AUTOANTIBODI….. Novi Dwi Anggraini
COVERPERSETUJUANPERNYATAANPENGESAHANPENETAPAN PANITIA PENGUJIKATA PENGANTARUCAPAN TERIMA KASIHRINGKASANSUMMARYABSTRAKABSTRACTDAFTAR ISIDAFTAR GAMBARDAFTAR TABELDAFTAR LAMPIRANDAFTAR SINGKATANBAB 1 PendahuluanBAB 2 Tinjauan KepustakaanBAB 3 Kerangka KonseptualBAB 4 Metodologi PenelitianBAB 5 Hasil Penelitian revisiBAB 6 PembahasanBAB 7 KesimpulanDAFTAR PUSTAKALAMPIRAN